GH Guardant Health, Inc.

NASDAQ
$168.58

Guardant Health, Inc. (GH) is confirmed to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.29 per share.

Guardant Health Missed Expectations, Raises Guidance In-line with Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
($0.28)
vs ($0.29) (non-GAAP) +$0.01
Rev est $350.83M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $168.14

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Guardant Health, Inc.

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.